Short-acting non-depolarizing blocker
**Core Concept**
The question is asking about a specific class of neuromuscular blocking agents that induce muscle relaxation by competitively blocking acetylcholine receptors at the neuromuscular junction, but have a shorter duration of action compared to intermediate-acting agents.
**Why the Correct Answer is Right**
Short-acting non-depolarizing blockers, such as atracurium or mivacurium, act by competitively blocking the nicotinic acetylcholine receptors at the neuromuscular junction. This blocks the action of acetylcholine, the neurotransmitter released by motor neurons, thereby preventing muscle contraction. These agents have a rapid onset of action and a short duration of action, typically lasting between 15-30 minutes. This makes them suitable for procedures requiring brief periods of muscle relaxation.
**Why Each Wrong Option is Incorrect**
**Option A:** Vecuronium is an intermediate-acting non-depolarizing blocker, not short-acting. It has a duration of action that is longer than the agents classified as short-acting.
**Option B:** Rocuronium is an intermediate-acting non-depolarizing blocker, not short-acting. Although it has a rapid onset of action, its duration of action is longer than the agents classified as short-acting.
**Option C:** Succinylcholine is a depolarizing neuromuscular blocker, not a non-depolarizing agent. It works by mimicking the action of acetylcholine, leading to initial muscle contraction followed by prolonged muscle relaxation.
**Clinical Pearl / High-Yield Fact**
When choosing a neuromuscular blocking agent, it's essential to consider the duration of action and the desired clinical effect. Short-acting agents like atracurium or mivacurium are suitable for procedures requiring brief periods of muscle relaxation, while intermediate-acting agents like vecuronium or rocuronium are better suited for longer procedures.
**Correct Answer:** D. Mivacurium